Cytogenetics are a predictive factor of response to low dose Ara-C in acute myelogenous leukemia (AML) in the elderly
Leukemia
.
1990 Apr;4(4):312.
Authors
P Fenaux
,
J L Lai
,
C Gardin
,
F Bauters
PMID:
2366585
No abstract available
Publication types
Letter
MeSH terms
Aged*
Cytarabine / therapeutic use*
Female
Gene Rearrangement
Humans
Karyotyping
Leukemia, Myeloid, Acute / drug therapy
Leukemia, Myeloid, Acute / genetics*
Male
Middle Aged
Substances
Cytarabine